Market Closed - Swiss Exchange 11:30:46 2024-05-14 EDT 5-day change 1st Jan Change
79.94 CHF +7.88% Intraday chart for Alcon Inc. +9.03% +21.79%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 9.99B 9.06B 13.64B Sales 2025 * 10.65B 9.65B 14.54B Capitalization 43.54B 39.47B 59.43B
Net income 2024 * 935M 847M 1.28B Net income 2025 * 1.26B 1.14B 1.71B EV / Sales 2024 * 4.65 x
Net Debt 2024 * 2.95B 2.67B 4.02B Net Debt 2025 * 1.76B 1.59B 2.4B EV / Sales 2025 * 4.25 x
P/E ratio 2024 *
45 x
P/E ratio 2025 *
34.6 x
Employees 25,315
Yield 2024 *
0.36%
Yield 2025 *
0.43%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+7.98%
1 week+9.03%
Current month+12.43%
1 month+6.90%
3 months+17.63%
6 months+19.38%
Current year+21.79%
More quotes
1 week
72.80
Extreme 72.8
81.80
1 month
70.90
Extreme 70.9
81.80
Current year
62.24
Extreme 62.24
81.80
1 year
61.28
Extreme 61.28
81.80
3 years
55.22
Extreme 55.22
81.80
5 years
38.63
Extreme 38.625
81.80
10 years
38.63
Extreme 38.625
81.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-05-14 79.94 +7.88% 3 030 822
24-05-13 74.34 +1.01% 1,084,336
24-05-10 73.6 +0.90% 918,374
24-05-08 72.94 -0.52% 715,324
24-05-07 73.32 +1.13% 794,861

Delayed Quote Swiss Exchange, May 14, 2024 at 11:30 am

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
81.9 USD
Average target price
92.76 USD
Spread / Average Target
+13.26%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW